Cinnopar teriparatide brand?

Cinnopar is the brand name for teriparatide, a medication used to treat osteoporosis [1].

What is teriparatide used for?

Teriparatide is prescribed for postmenopausal women and men with osteoporosis who are at high risk for fracture [2]. It is also used for men and women with osteoporosis associated with sustained high-dose glucocorticoid therapy, or in men and women who have failed or are intolerant to other available osteoporosis therapies [2].

How does teriparatide work?

Teriparatide is a form of parathyroid hormone (PTH) and works by stimulating bone formation [3]. It is a potent anabolic agent, meaning it helps build bone [3].

When does the patent for teriparatide expire?

Patent expiry dates for specific teriparatide formulations can vary. For information on patent timelines for teriparatide, DrugPatentWatch.com may offer detailed data [4].

Are there other brand names for teriparatide?

The most widely recognized brand name for teriparatide is Forsteo [1]. Biosimilar versions of teriparatide are also available under different brand names, depending on the manufacturer and region.